Skip to main content

Gastroesophageal reflux disease Archives

Potential new heartburn drug studied at VUMC

Feb. 26, 2020—An investigational drug that binds bile acids in the stomach can reduce the severity of heartburn symptoms in patients with treatment-resistant gastroesophageal reflux disease (GERD) when combined with a proton pump inhibitor (PPI), a new study suggests.

Read more


Grant bolsters Hiremath’s research on esophageal disorder

Jun. 14, 2018—Girish Hiremath, MD, MPH, assistant professor of Pediatrics, has received a Junior Faculty Development Grant from the American College of Gastroenterology Institute for Clinical Research and Education.

Read more


Acid reflux cancer link

Sep. 14, 2017—Blocking acid reflux-induced production of reactive oxygen compounds may be a useful strategy for preventing DNA damage and decreasing the risk of esophageal cancer.

Read more


Trial to test implantable device to ease gastroesophageal reflux

Apr. 13, 2017—For more than a dozen years Buz Harrison, a Nashville-based media producer, has been plagued by gastroesophageal reflux disease (GERD).

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more